<DOC>
	<DOCNO>NCT02209740</DOCNO>
	<brief_summary>Renal outcome could different switch tenofovir different antiretroviral strategy , case renal toxicity . Therefore , necessary evaluate importance renal evolution patient , term grade time renal improvement , accord different option interrupt tenofovir . The aim study explore renal outcome tenofovir accord new antiretroviral regimen .</brief_summary>
	<brief_title>Renal Bone Outcome After Switching Tenofovir Different Antiretroviral Strategies</brief_title>
	<detailed_description>Renal toxicity become important issue large number HIV infect patient receive tenofovir-containing regimen . However , data best antiretroviral regimen patient switch tenofovir renal toxicity , time , grade persistence renal improvement . Thus , patient renal toxicity tenofovir , define : - progressive decrease least 25 % estimate glomerular filtration rate ( GFR , chronic kidney disease-epi equation ) , - confirm value GFR 60 ml/min two successive determination , - proximal tubular renal dysfunction , indicate presence least 3 follow parameter : proteinuria &gt; 150 mg/g ; excretion fractional phosphorus urine &gt; 20 % ; glucosuria &gt; 150 mg ; or/and tubular proteinuria/albuminuria ratio 0.4. change combination abacavir plus third drug , nucleoside analogues-free antiretroviral combination ( dual therapy , monotherapy ) follow 1 year establish time grade improvement ( define lack criterion ) .</detailed_description>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>HIVinfected patient Older 18 year Receiving Tenofovircontaining regimen , criterion renal toxicity ( see ) Switching antiretroviral regimen Pregnancy Patients receive prolonged therapy nephrotoxic drug Patients receive interrupt antiretroviral regimen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>renal toxicity , HIV , antiretroviral , outcome</keyword>
</DOC>